SALT LAKE CITY, June 30, 2021 – The Food Traceability Leadership Consortium (FTLC), formed in March with the support of ReposiTrak, Inc. to explore possible solutions to FDA’s proposed traceability regulations under the Food Safety Modernization Act (FSMA), announced three critical guidelines for its ongoing work. The optimal solution to the traceability challenge in the retail food industry, the Consortium declared, must have minimal cost that doesn’t impact margins or consumer prices, be easy to adopt, use and verify in order to drive universal adoption and meet or exceed FDA proposed regulations to prepare for the future.
The FTLC is focusing on FSMA requirements for last leg of the supply chain, retailer and wholesaler distribution to the stores, which is facing especially challenging traceability issues. ReposiTrak, Inc., the industry leader in supply chain compliance and quality management technology solutions with a user network of over 100,000 facilities, is providing its industry knowledge and experience to deliver success.
“The FTLC and ReposiTrak worked collaboratively developing the guidelines to ensure the traceability solution endorsed will get broad buy-in from all trading partners. We have also confirmed the biggest challenges caused by the FSMA regulations, notably capturing shipment level data as product moves through the supply chain and traceability from the distribution center to the store, and are now determining the capabilities needed to address them,” said Randy Fields, chairman and CEO of ReposiTrak. “Then we will find a solution that has those capabilities.”
The FTLC gave specifics on each of the three principles for a traceability solution:
Must have minimal cost that can’t impact margins or price to consumer Additional cost comes from new hardware, software, integrations, labor and training. The only way to avoid these costs is to rely on existing processes and documentation. The solution should accept any format of existing electronic documents or records being exchanged in the supply chain, and should not require changes in inventory management practices at the field, processing plant, DC or store.
Must be easy to adopt, to use and to verify in order to drive universal adoption The easiest system to use is one already deployed and allows participation by companies with any level of technical capability. It should identify and allow easy repair of breaks in the chain, and enable error checking.
Must meet or exceed FDA proposed regulations to prepare for the future The optimal solution should not be based on trust, but rather visibility to actual product movements through each node of the supply chain. It must also reduce or eliminate replication of effort and data, and simplify data exchange, retrieval and connectivity to universally accept all forms of data from any participant.
“We’ve made great progress in understanding the needs of the industry in a short time by sharing both pain points and successes. The FTLC will now work to see if there is a solution that addresses the FDA requirements while not interrupting supply chain operations or negatively impacting consumer costs,” said Fields.
The FTLC welcomes inquiries from retailers, wholesalers and suppliers interested in joining the group. For more information, contact Derek Hannum, SVP of Customer Success for ReposiTrak at 435-645-2230 or email@example.com.
ReposiTrak, Park City Group, Inc. (NASDAQ: PCYG), provides retailers, suppliers and public sector agencies with a robust solution suite to help reduce risk and remain in compliance with regulatory requirements; enhance operational controls; source and discover new vendors; and increase sales with unrivaled brand protection. Consisting of three product families—compliance and risk management, supply chain solutions and MarketPlace sourcing—ReposiTrak’s cloud-based platform’s integrated applications are mutually reinforcing and work synergistically to create value and positive impact.
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “if”, “should” and “will” and similar expressions as they relate to Park City Group, Inc. (“Park City Group”) are intended to identify such forward-looking statements. Park City Group may from time to time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see “Risk Factors” in Park City’s annual report on Form 10-K, its quarterly report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.